Fiera Capital (Canada)
GRCE

Fiera Capital (Canada)’s Grace Therapeutics GRCE Stock Holding History

Fiera Capital (Canada)’s Portfolio GRCE Stock Details GRCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,295
Closed -$1.55M – 604
2015
Q3 		$1.55M Sell
1,295
-833
-39% -$140K 0.01% 342
2015
Q2 		$327 Sell
2,128
-1,009
-32% -$188K ﹤0.01% 478
2015
Q1 		$722K Sell
3,137
-231
-7% -$54.4K 0.01% 392
2014
Q4 		$808K Hold
3,368
– – 0.01% 396
2014
Q3 		$1.25M Hold
3,368
– – 0.01% 389
2014
Q2 		$1.65M Buy
+3,368
New +$1.61M 0.01% 369

Other funds holding GRCE

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CS
Credential Securities Vancouver $440M AUM 9.75% 1-Year Est. Return

Fiera Capital (Canada)'s GRCE Position: Q4 2015 in Review

Fiera Capital (Canada) sold out of Grace Therapeutics (GRCE) in Q4 2015, closing a stake of 1,295 shares — an estimated $1.55M sold.

Fiera Capital (Canada) first reported a position in GRCE in Q2 2014 and held it in 6 quarters. The position peaked at $1.65M in Q2 2014. 12 funds tracked by Wall St. Rank hold GRCE as of Q4 2015.

  • Fiera Capital (Canada) reported no remaining Grace Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Fiera Capital (Canada) sold 1,295 Grace Therapeutics shares in Q4 2015, an estimated $1.55M.
  • Fiera Capital (Canada) first reported a position in Grace Therapeutics in Q2 2014 and held it in 6 quarters.
  • Fiera Capital (Canada)'s Grace Therapeutics position peaked at $1.65M in Q2 2014.
  • 12 funds tracked by Wall St. Rank held Grace Therapeutics as of Q4 2015.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2015, filed 16 Feb 2016.